ONY Biotech


A small, privately-held, and family-focused neonatology pharmaceutical company, ONY Biotech is a leader in the creation of critically important products for the treatment of premature infants. They innovate with a singular purpose: to improve outcomes for premature babies and their families.

Industries

Employees

11-50

Links


Org chart

Randy Burkard
President & CEO
Collapse
James Cummings
Chief Medical Officer
Edmund Egan
Founder, Chairman & Chief Scientific Officer
Jennifer Kelchlin
Chief Financial Officer
Jonathan Miller
Director, U.S. Sales
John Kaminski
Director, National Accounts
David Verner
Chief Operating Officer
Kimberly Czajka
Director Of International Sales